Camden National (CAC)
(Real Time Quote from BATS)
$40.40 USD
+0.16 (0.40%)
Updated Aug 26, 2024 12:15 PM ET
2-Buy of 5 2
C Value F Growth F Momentum F VGM
Income Statements
Fiscal Year end for Camden National Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 257 | 213 | 198 | 208 | 211 |
Cost Of Goods | 79 | 20 | 8 | 16 | 34 |
Gross Profit | 178 | 193 | 190 | 192 | 177 |
Selling & Adminstrative & Depr. & Amort Expenses | 109 | 111 | 101 | 112 | 98 |
Income After Depreciation & Amortization | 69 | 82 | 90 | 80 | 78 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 15 | 5 | 3 | 5 | 7 |
Pretax Income | 54 | 77 | 87 | 74 | 72 |
Income Taxes | 10 | 16 | 18 | 15 | 14 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 43 | 61 | 69 | 59 | 57 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 43 | 61 | 69 | 59 | 57 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 75 | 90 | 101 | 89 | 86 |
Depreciation & Amortization (Cash Flow) | 6 | 8 | 11 | 9 | 8 |
Income After Depreciation & Amortization | 69 | 82 | 90 | 80 | 78 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 14.61 | 14.73 | 15.00 | 15.06 | 15.50 |
Diluted EPS Before Non-Recurring Items | 3.63 | 4.19 | 4.60 | 3.95 | 3.69 |
Diluted Net EPS (GAAP) | 2.97 | 4.17 | 4.60 | 3.95 | 3.69 |
Fiscal Year end for Camden National Corporation falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 72.81 | 70.51 | 65.78 | 62.74 | 66.17 |
Cost Of Goods | 24.17 | 23.18 | 22.84 | 20.97 | 19.25 |
Gross Profit | 48.64 | 47.33 | 42.94 | 41.77 | 46.92 |
SG&A, R&D, and Dept/Amort Expenses | 27.96 | 25.26 | 28.42 | 25.64 | 27.25 |
Income After SG&A, R&D, and Dept/Amort Expenses | 20.68 | 22.07 | 14.52 | 16.13 | 19.67 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 5.81 | 5.73 | 4.25 | 4.12 | 4.12 |
Pretax Income | 14.87 | 16.34 | 10.28 | 12.02 | 15.55 |
Income Taxes | 2.88 | 3.06 | 1.80 | 2.24 | 3.17 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 11.99 | 13.27 | 8.48 | 9.79 | 12.39 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 11.99 | 13.27 | 8.48 | 9.79 | 12.39 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 14.63 | 14.59 | 14.57 | 14.61 | 14.58 |
Diluted EPS Before Non-Recurring Items | 0.81 | 0.86 | 0.85 | 0.96 | 0.85 |
Diluted Net EPS (GAAP) | 0.81 | 0.91 | 0.58 | 0.67 | 0.85 |